Comparative effectiveness of statin therapy in patients with hypertension of high and very high cardiovascular risk in actual clinical practice in Irkutsk

QR Code

Comparative effectiveness of statin therapy in patients with hypertension of high and very high cardiovascular risk in actual clinical practice in Irkutsk

Aim. To study lipid-lowering therapy in patients with high and very high risk of cardiovascular events (CVEs) at the outpatient and inpatient care stages in Irkutsk.Material and methods. We analyzed 260 discharge summaries of patients with hypertension of high and very high risk of CVEs for the seco...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. A. Ivanova, S. G. Kuklin, S. S. Sizova, T. A. Novoselova, L. R. Gaifullina
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2021-11-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	lipid-lowering therapy statins high and very high risk cardiovascular events morisky-green test
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/3073
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of inclisiran, evolocumab and alirocumab in patients with high, very high and extreme cardiovascular risk
by: N. G. Lozhkina, et al.
Published: (2025-04-01)

Statin therapy in patients with high and very high cardiovascular risk: an optimal approach
by: E. V. Sayutina, et al.
Published: (2020-11-01)

Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis
by: N. E. Gavrilova, et al.
Published: (2015-11-01)

Atorvastatin effectiveness and safety in patients with high cardiovascular risk. Revising the results of the OSCAR Study (2006)
by: S. A. Shalnova, et al.
Published: (2010-12-01)

New perspectives in treating high-risk cardiac patients. Rosuvastain and it’s perspectives for clinical practice use
by: M. G. Bubnova
Published: (2007-12-01)

Register of patients with familial hypercholesterolemia and patients of very high cardiovascular risk with lipid-lowering therapy underperformance (RENESSANS)
by: M. V. Yezhov, et al.
Published: (2019-06-01)

Efficacy and safety of statin therapy in multimorbid outpatients with very high cardiovascular risk
by: N. V. Izmozherova, et al.
Published: (2020-07-01)

Rhabdomyolysis as a rare severe complication of statin therapy: differential diagnosis in real clinical practice (a clinical case)
by: A. V. Melekhov, et al.
Published: (2025-06-01)

A novel approach with quadrupole magnets for precise deflection, scattering and focusing of very high energy electron beams (VHEE)
by: Mustapha Assalmi, et al.
Published: (2025-06-01)

Barriers for statin prescription in real-world clinical practice (results of a survey among Krasnodar City and Krasnodar Region doctors)
by: V. V. Skibitsky, et al.
Published: (2008-06-01)

Long-Term Outcomes After High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiotherapy in Very High-Risk Prostate Cancer: A 24-Year Follow-Up
by: Pedro J. Prada Gómez, et al.
Published: (2025-05-01)

Statin-Induced Myopathy
by: D. A. Sychev, et al.
Published: (2023-09-01)

Pharmacotherapy with statins in highand very high-risk elderly patients
by: V. V. Simerzin, et al.
Published: (2020-11-01)

Intensification of lipid-lowering therapy in very high-risk patients: potential of combination with PCSK9 inhibitors
by: D. Yu. Sedykh, et al.
Published: (2022-07-01)

FATIGUE CRACKING MECHANISMS OF TITANIUM ALLOY VT3-1 IN VERY-HIGH-CYCLE-FATIGUE REGIME
by: A. A. Shanyavskiy, et al.
Published: (2016-11-01)

Establishing Linearity of the MOS<i>kin</i> Detector for Ultra-High Dose-per-Pulse, Very-High-Energy Electron Radiotherapy Using Dose-Rate-Corrected EBT-XD Film
by: James Cayley, et al.
Published: (2025-07-01)

MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER)
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

Adherence to statin therapy in patients with high and very high cardiovascular risk in real clinical practice
by: V. I. Podzolkov, et al.
Published: (2020-03-01)

REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER)
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

EFFECTIVENESS OF ROSUVASTATIN IN VERY HIGH RISK CARDIOVASCULAR PATIENTS IN THE ACTUAL OUTPATIENT PRACTICE
by: V. P. Mikhin, et al.
Published: (2015-12-01)

Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity?
by: A. M. Chaulin, et al.
Published: (2023-05-01)

Moderate-intensity statin therapy. Efficacy and safety issues
by: N. G. Gogolashvili
Published: (2023-07-01)

Interdisciplinary Expert Consensus: the place of original pitavastatin in primary and secondary prevention of cardiovascular diseases
by: M. G. Bubnova, et al.
Published: (2024-12-01)

A randomized controlled trial of statin therapy effect on androgen status and erectile function in men with high and very high cardiovascular risk (TRISTAN): rationale and study protocol
by: K. P. Raevskii, et al.
Published: (2025-06-01)

The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists
by: Marina G. Bubnova, et al.
Published: (2025-01-01)

Optimal strategy for very high-power short-duration atrial fibrillation ablation: Acute efficacy and safety of pulmonary vein and box isolation
by: Yusuke Sakamoto, et al.
Published: (2025-05-01)

The prognostic value of various markers of lower limb atherosclerotic lesions in patients with high and very high cardiovascular risk
by: V. V. Genkel, et al.
Published: (2019-06-01)

An injector testbed based on a direct current gun and an interchangeable very high frequency gun for superconducting continuous-wave free-electron lasers
by: Xinmeng Li, et al.
Published: (2025-07-01)

Features and main problems of treating patients with high and very high cardiovascular risk with statins in real clinical practice (according to the data of the “PRIORITET” research)
by: S. Yu. Martsevich, et al.
Published: (2018-12-01)

THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT?
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

Adherence to urate-lowering therapy while following the national guidelines for the management of patients with gout (preliminary evidence)
by: M. N. Chikina, et al.
Published: (2020-11-01)

High-risk patients: modern treatment strategy
by: D. V. Nebieridze, et al.
Published: (2010-12-01)

Safety of Lipid-Lowering Therapy with Statins according to a Regional Pharmacovigilance Centre
by: E. O. Kochkina, et al.
Published: (2023-09-01)

Uncontrolled Hypertension among Older Hypertensive Patients and Their Drug Adherence Pattern
by: K. Umakalyani, et al.
Published: (2025-04-01)

The “16‐gram window” of contact‐force: A new criterion for very high‐power short‐duration ablation
by: Dimitrios Bismpos, et al.
Published: (2025-06-01)

Lipid-lowering therapy in patients with coronary artery disease in primary care practices: what has changed over 7 years?
by: S. K. Zyryanov, et al.
Published: (2020-09-01)

Clinical, lipid-lowering, and pleiotropic effectiveness of rosuvastatin: a review of the GALAXY programme results
by: A. N. Britov, et al.
Published: (2011-02-01)

THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015
by: S. A. Smetnev, et al.
Published: (2017-01-01)

Actual issues of lipid centers’ operation in Russian Federation
by: S. Boytsov, et al.
Published: (2021-02-01)

High-Power-Density Miniaturized VLF Antenna with Nanocrystalline Core for Enhanced Field Strength
by: Wencheng Ai, et al.
Published: (2025-07-01)